SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parnax Lab - Quaterly Results

14 Feb 2022 Evaluate
The sales for the December 2021 quarter moved down -32.26% to Rs. 4.62 millions as compared to Rs. 6.82 millions during the year ago period.The Net Loss for the quarter ended December 2021 is Rs. -3.24 millions as compared to Net Loss of Rs. -3.14 millions of corresponding quarter ended December 2020 Operating profit Margin for the quarter ended December 2021 further decreased to -1.43% as compared to -0.90% of corresponding quarter ended December 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 4.62 6.82 -32.26 45.24 16.00 182.75 23.73 76.79 -69.10
Other Income 0.23 0.28 -17.86 0.95 0.60 58.33 0.65 4.16 -84.38
PBIDT -1.43 -0.90 58.89 6.76 -1.76 -484.09 -3.79 9.50 -139.89
Interest 1.71 2.13 -19.72 5.36 6.50 -17.54 8.30 13.79 -39.81
PBDT -3.14 -3.03 3.63 1.40 -8.26 -116.95 -12.09 -4.29 181.82
Depreciation 0.10 0.11 -9.09 0.30 0.33 -9.09 0.44 0.44 0.00
PBT -3.24 -3.14 3.18 1.10 -8.59 -112.81 -12.53 -4.73 164.90
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -1.23 15.33 -108.02
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -2.56 15.33 -116.70
PAT -3.24 -3.14 3.18 1.10 -8.59 -112.81 -11.30 -20.06 -43.67
Equity 85.05 85.05 0.00 85.05 85.05 0.00 85.05 85.05 0.00
PBIDTM(%) -30.95 -13.20 134.55 14.94 -11.00 -235.84 -15.97 12.37 -229.10

Parnax Lab Share Price

163.85 1.15 (0.71%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×